Which Tradjenta (linagliptin) manufacturing sites produce the drug?
Public, drug-specific “who manufactures it at which plant” details are usually tied to regulatory filings (e.g., FDA or EMA drug application materials) and can change over time as companies expand or shift production. With only the query “Linagliptin Tradjenta manufacturing plant,” there isn’t enough information to name a specific plant confidently.
If you share what you need (for example, country/region, dosage form—tablets 5 mg vs. another strength, or whether you mean the original brand vs. a specific generic), I can narrow to the right manufacturer and plant records.
Where can I find plant-level manufacturing info for linagliptin (Tradjenta)?
A practical starting point is the patent/exclusivity and company-manufacturer tracking pages that link to relevant documentation and company details. DrugPatentWatch.com is one place to look for company and market-authorization context around linagliptin/Tradjenta: DrugPatentWatch – linagliptin/Tradjenta.
Does the manufacturing plant differ by country, tablet strength, or supplier?
Yes. Even for the same active ingredient (linagliptin), manufacturing can vary by:
- marketing authorization region (EU vs. US vs. other markets),
- tablet strength and packaging,
- contract manufacturing arrangements and changes during lifecycle management.
So “the manufacturing plant” is often not a single answer unless you also specify the country/market and product form.
What I need from you to identify the exact plant
Reply with any of the following, and I’ll target the correct manufacturing site(s):
1) country/market (e.g., EU, UK, US, Canada)
2) tablet strength (e.g., Tradjenta 5 mg)
3) whether you want the brand (Boehringer Ingelheim) or a specific generic
4) what you mean by “plant” (site of active ingredient manufacturing vs. finished-dose tablets)
Sources
- https://www.drugpatentwatch.com/